Gene · 9100
Papers1,422
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,422
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Isoform Remodeling and Promoter Switching Identify Altered Transcriptional Regulation in Alzheimer's Disease Frontal Cortex. | Res Sq | 2026 | 42818937 | PubTator, text mining | PubMed |
| USP10 stabilizes FOXM1 through KAT5-mediated acetylation to suppress cell senescence and promote melanoma malignant progression. | Int J Biol Sci | 2026 | 42807929 | PubTator, text mining | PubMed |
| Stress granules and RNA-binding proteins in cellular senescence: a modular perspective on stress adaptation and inflammation. | Mol Biol Rep | 2026 | 42789125 | PubTator, text mining | PubMed |
| Regulatory roles of five key USP family deubiquitinases in cancer: from mechanisms to targeted therapy advances. | Front Pharmacol | 2026 | 42787673 | PubTator, text mining | PubMed |
| USP10 is associated with TUBA1B protein stability, PI3K/AKT phosphorylation changes, and progression of triple-negative breast cancer. | Pathol Res Pract | 2026 | 42727187 | PubTator, text mining | PubMed |
| Deubiquitination of NICD1 by USP10 Restrains Esophageal Cancer: A Link Between NOTCH1 Stabilization, Oxidative Stress, and Ferroptosis. | Neoplasia | 2026 | 42710266 | PubTator, text mining | PubMed |
| USP10-dependent stabilization of UGT8 promotes oxaliplatin resistance by sustaining NRF2-associated antioxidant signaling and suppressing ferroptosis in gastric cancer. | Free Radic Biol Med | 2026 | 42648560 | PubTator, text mining | PubMed |
| G3BP1 depletion, observed in Parkinson's Disease, drives Golgi-lysosome-autophagy defects. | Cell Death Differ | 2026 | 42642486 | PubTator, text mining | PubMed |
| IL-6 Promotes Pathological Angiogenesis in Oral Submucous Fibrosis by Suppressing USP10-VEGFR1 Interaction. | J Cell Mol Med | 2026 | 42619043 | PubTator, text mining | PubMed |
| Targeting Ubiquitinated Protein Aggregates in Neurodegenerative Diseases: current Status and Future Directions. | Mol Cell Biol | 2026 | 42549923 | PubTator, text mining | PubMed |
| USP10-SIRT6-PARP1 axis drives keratinocyte senescence and skin photoaging under chronic UVA exposure. | Int Immunopharmacol | 2026 | 42537350 | PubTator, text mining | PubMed |
| VASN Enhances IGF2BP3 Stability via USP10 Deubiquitination to Promote Triple-negative Breast Cancer Paclitaxel Resistance. | Int J Biol Sci | 2026 | 42524640 | PubTator, text mining | PubMed |
| Hsa_circ_0006969 aggravates keratinocytes from high-glucose injury by sponging miR-375 to promote USP10 and SCD expression. | Funct Integr Genomics | 2026 | 42521882 | PubTator, text mining | PubMed |
| Ubiquitin-Related Proteostatic Programs in Cycling Fibroblast-Lineage Remodeling After Myocardial Ischemic Injury: A Hypothesis Informed by Single-Cell and Spatial Transcriptomics. | Int J Mol Sci | 2026 | 42511877 | PubTator, text mining | PubMed |
| AMZ2 facilitates oral squamous cell carcinoma progression via USP10-mediated deubiquitination of SF3B1 and regulation of MCL-1 alternative splicing. | J Craniomaxillofac Surg | 2026 | 42424707 | PubTator, text mining | PubMed |
| PRMT5-Dependent Stabilization of VPS34 Orchestrates Copper Trafficking to Shield Cancer Cells from Cuproptosis and Radiotherapy. | Adv Sci (Weinh) | 2026 | 42419369 | PubTator, text mining | PubMed |
| PFKFB4 Deubiquitination by USP10 Enhances Fumarate Metabolism to Orchestrate the KDM1A/Rad51 Axis and Confer Radioresistance in Lung Cancer. | Adv Sci (Weinh) | 2026 | 42417500 | PubTator, text mining | PubMed |
| Corrigendum to "Acacetin ameliorates pressure overload-induced cardiac remodeling by targeting USP10 and inhibiting maladaptive cardiomyocyte autophagy" [Phytomedicine 141C (2025) 156588]. | Phytomedicine | 2026 | 42365691 | PubTator, text mining | PubMed |
Large-scale transcriptomic data mining using explainable XGBoost and SHAP reveals shared biomarkers and molecular mechanisms between type-2 diabetes and triple-negative breast cancer for drug repurposing. | BioData Min | 2026 | 42316306 | PubTator, text mining | PubMed |
| Multiaxial Biophysical Control of Oncogenic Phase Separation by Indoleamines: A Proof-of-Concept Synthesis of Landscape-Level Regulation. | J Pineal Res | 2026 | 42306984 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9100/papers